My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 139

    1.

    Lymphatic Filariasis (Elephantiasis) Elimination: A public health success and development opportunity.

    Molyneux D.

    Filaria J. 2003 Sep 9;2(1):13.PMID: 13129436 [PubMed - as supplied by publisher]Related articlesFree article

    2.

    The Elimination of Lymphatic Filariasis: A Strategy for Poverty Alleviation and Sustainable Development - Perspectives from the Philippines.

    Galvez Tan JZ.

    Filaria J. 2003 Jul 21;2(1):12.PMID: 12914666 [PubMed - as supplied by publisher]Related articlesFree article

    3.

    [ Bancroftian lymphatic filariasis: toward its elimination from the Pacific?]

    Chanteau S, Roux JF.

    Bull Soc Pathol Exot. 2008 Jun;101(3):254-60. French. PMID: 18681220 [PubMed - indexed for MEDLINE]Related articles

    4.

    Current status and future prospects of the Global Lymphatic Filariasis Programme.

    Molyneux DH, Taylor MJ.

    Curr Opin Infect Dis. 2001 Apr;14(2):155-9. Review.PMID: 11979126 [PubMed - indexed for MEDLINE]Related articles

    5.

    Mathematical models for lymphatic filariasis transmission and control: Challenges and prospects.

    Swaminathan S, Subash PP, Rengachari R, Kaliannagounder K, Pradeep DK.

    Parasit Vectors. 2008 Feb 12;1(1):2.PMID: 18275593 [PubMed - in process]Related articlesFree article

    6.

    The global programme to eliminate lymphatic filariasis.

    Ottesen EA.

    Trop Med Int Health. 2000 Sep;5(9):591-4.PMID: 11044272 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Lymphatic filariasis in the Eastern Mediterranean Region: current status and prospects for elimination.

    El Setouhy M, Ramzy RM.

    East Mediterr Health J. 2003 Jul;9(4):534-41. Review.PMID: 15748050 [PubMed - indexed for MEDLINE]Related articles

    8.

    Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.

    Flynn MA, McNeil DA, Maloff B, Mutasingwa D, Wu M, Ford C, Tough SC.

    Obes Rev. 2006 Feb;7 Suppl 1:7-66. Review.PMID: 16371076 [PubMed - indexed for MEDLINE]Related articles

    9.

    The global programme to eliminate lymphatic filariasis: health impact after 8 years.

    Ottesen EA, Hooper PJ, Bradley M, Biswas G.

    PLoS Negl Trop Dis. 2008 Oct 8;2(10):e317.PMID: 18841205 [PubMed - in process]Related articlesFree article

    10.

    Salt fortified with diethylcarbamazine (DEC) as an effective intervention for lymphatic filariasis, with lessons learned from salt iodization programmes.

    Houston R.

    Parasitology. 2000;121 Suppl:S161-73. Review.PMID: 11386687 [PubMed - indexed for MEDLINE]Related articles

    11.

    Editorial: Global elimination of lymphatic filariasis: fact or fantasy?

    Gyapong JO, Twum-Danso NA.

    Trop Med Int Health. 2006 Feb;11(2):125-8.PMID: 16451335 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Health Related Quality of Life, an appropriate indicator to assess the impact of morbidity management and disability prevention activities towards elimination of lymphatic filariasis.

    Kumari AK, Krishnamoorthy K, Harichandrakumar K, Das L.

    Filaria J. 2007 Aug 28;6:8.PMID: 17723155 [PubMed - in process]Related articlesFree article

    13.

    Certifying lymphatic filariasis elimination in the Pacific--the need for new tools.

    Durrheim DN, Nelesone T, Speare R, Melrose W.

    Pac Health Dialog. 2003 Sep;10(2):149-54.PMID: 18181427 [PubMed - indexed for MEDLINE]Related articles

    14.

    Control of human parasitic diseases: Context and overview.

    Molyneux DH.

    Adv Parasitol. 2006;61:1-45. Review.PMID: 16735161 [PubMed - indexed for MEDLINE]Related articles

    15.

    GlaxoSmithKline and Merck: private-sector collaboration for the elimination of lymphatic filariasis.

    Gustavsen KM, Bradley MH, Wright AL.

    Ann Trop Med Parasitol. 2009 Oct;103 Suppl 1:S11-5.PMID: 19843393 [PubMed - in process]Related articles

    16.

    Lymphatic filariasis: Treatment, control and elimination.

    Ottesen EA.

    Adv Parasitol. 2006;61:395-441. Review.PMID: 16735170 [PubMed - indexed for MEDLINE]Related articles

    17.

    National mass drug administration costs for lymphatic filariasis elimination.

    Goldman AS, Guisinger VH, Aikins M, Amarillo ML, Belizario VY, Garshong B, Gyapong J, Kabali C, Kamal HA, Kanjilal S, Kyelem D, Lizardo J, Malecela M, Mubyazi G, Nitièma PA, Ramzy RM, Streit TG, Wallace A, Brady MA, Rheingans R, Ottesen EA, Haddix AC.

    PLoS Negl Trop Dis. 2007 Oct 31;1(1):e67.PMID: 17989784 [PubMed - in process]Related articlesFree article

    18.

    Eliminating lymphatic filariasis: a view from the field.

    Streit T, Lafontant JG.

    Ann N Y Acad Sci. 2008;1136:53-63.PMID: 18579875 [PubMed - indexed for MEDLINE]Related articles

    19.

    The Global Programme to Eliminate Lymphatic Filariasis: health impact during its first 8 years (2000-2007).

    Hooper PJ, Bradley MH, Biswas G, Ottesen EA.

    Ann Trop Med Parasitol. 2009 Oct;103 Suppl 1:S17-21.PMID: 19843394 [PubMed - in process]Related articles

    20.

    Mass drug administration to eliminate lymphatic filariasis in India.

    Ramaiah KD, Das PK.

    Trends Parasitol. 2004 Nov;20(11):499-502.PMID: 15471698 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity